Kookjeon Pharmaceutical Co., Ltd. (KOSDAQ:307750)
3,075.00
+80.00 (2.67%)
At close: May 21, 2026
Kookjeon Pharmaceutical Market Cap
Kookjeon Pharmaceutical has a market cap or net worth of 166.01 billion as of May 21, 2026. Its market cap has increased by 5.64% in one year.
Market Cap
166.01B
Enterprise Value
180.92B
Revenue
131.04B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,075.00
Market Cap Chart
Since December 16, 2020, Kookjeon Pharmaceutical's market cap has increased from 37.63B to 166.01B, an increase of 341.22%. That is a compound annual growth rate of 31.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 161.69B | -4.24% |
| Dec 30, 2025 | 168.84B | -2.11% |
| Dec 30, 2024 | 172.48B | -43.67% |
| Dec 28, 2023 | 306.19B | -5.74% |
| Dec 29, 2022 | 324.84B | -39.54% |
| Dec 30, 2021 | 537.31B | 40.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| High Tech Pharm | 163.75B |
| Knowmerce | 162.98B |
| Chemtros | 162.93B |
| CORESTEMCHEMON | 162.58B |
| CG MedTech | 162.12B |
| HB SOLUTION | 161.28B |
| Powernet Technologies | 160.70B |
| Genic | 160.41B |